Personalized Nutrition: Ethical and Regulatory Aspects
Oct 24, 2011
from 3:00 PM to 4:00 PM
|Where||Greg Sutliff Auditorium, Lewis Katz Building|
|Add event to calendar||
Chair of Innovation in the Life Sciences, ESRC Innogen Centre, University of Edinburgh
David Castle is Professor and Chair of Innovation in the Life Sciences at the University of Edinburgh. His research focuses on social aspects of life science innovation including democratic engagement, regulation and governance, and intellectual property and knowledge management. He has published extensively on the social dimensions of science, technology and innovation, has held several major research awards, and has considerable experience leading strategic research initiatives and research project management. Prof. Castle has consulted widely to government and industry on issues such as the impact of national technology transfer policies and programs, intellectual property and knowledge management strategies, and the role of non-scientific considerations in the regulation of science and technology.
"Personalized Nutrition: Ethical and Regulatory Aspects"
View this lecture
To access this presentation on the Web, please click on the "MediaSite" icon. (You must have Windows Media Player and Internet Explorer 5.5 or higher, or Microsoft Silverlight to view presentations.)
Translating insights from the human genome project (HGP) into innovations that improve health care, like more and better diagnostics, will occupy an entire generation of researchers. A central motivation underlying the HGP has been to bridge the gap between generaliZed human genomic knowledge and individual genetic applications. Personalized medicine remains in the future, but achieving some measure of personalization in nutrition may have better prospects. Nutritional genomics and genetics—aka "nutrigenomics"—has been the object of intense ethical and regulatory scrutiny, however, in part because of early direct-to-consumer offers. While concerns about safety must be explored, an overarching framework for assessing risks and benefits has not been agreed upon, much less deployed. A piecemeal approach to weighing ethical and regulatory considerations regarding new science and technology raises problems that will be discussed in the context of personalized nutrition.